Article Text

PDF
Extended report
Epistasis between two HLA antigens defines a subset of individuals at a very high risk for ankylosing spondylitis
  1. Floris A van Gaalen1,
  2. Willem Verduijn2,
  3. Dave L Roelen2,
  4. Stefan Böhringer3,
  5. Tom W J Huizinga1,
  6. Désirée M van der Heijde1,
  7. René E M Toes1
  1. 1Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
  2. 2Department of Immunohaematology and Bloodtransfusion, Leiden University Medical Center, Leiden, The Netherlands
  3. 3Department of Biostatistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands
  1. Correspondence to Dr Floris A van Gaalen, Department of Rheumatology, Leiden University Medical Center, C4-R, PO Box 9600, Leiden 2300 R, The Netherlands; f.a.van_gaalen{at}lumc.nl

Abstract

Objectives Susceptibility to spondyloarthritis (SpA) is largely genetically determined. To understand increasingly complex genetic associations, one approach is to study epistasis or genetic interactions. Several associations between HLA antigens and SpA including HLA-B27 have been reported. In this study, we investigated epistasis between common HLA class I risk antigens in ankylosing spondylitis (AS), the most typical form of SpA.

Methods In 154 patients with AS and 5584 controls, HLA class I antigens were analysed for association with AS. Biological interaction was analysed by investigating whether the effects of the risk factors combined departed from additivity.

Results Apart from the association with HLA-B27, we found an association between HLA-B60 and AS (OR 1.8; 95% CI 1.2 to 2.8). This was confirmed in a meta-analysis (OR 2.2; CI 1.8 to 2.8). While 18.2% of AS patients had both HLA-B27 and HLA-B60, this combination was found in only 0.4% of controls. Using AS patients without HLA-B27 and HLA-B60 as a reference, the relative risk (RR) for disease in HLA-B27−/HLA-B60+ patients was 1.2 (95% CI 0.3 to 4.1). For HLA-B27+/HLA-B60− the RR was 69 (95% CI 40 to 111) but increased to 342 (95% CI 147 to 708) in HLA-B27+/HLA-B60+ patients. For the interaction, the relative excess risk due to interaction was 251, the attributable proportion was 0.8 and the synergy index was 4.7. The interaction was confirmed in an independent cohort.

Conclusions There is a strong epistatic interaction between HLA-B60 and HLA-B27 in AS susceptibility. As a result, individuals with the HLA-B27+/HLA-B60+ genotype are at a very high risk of developing AS.

  • Ankylosing Spondylitis
  • Gene Polymorphism
  • Epidemiology

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.